Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Herceptin Biosimilar market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Herceptin Biosimilarmarket, defines the market attractiveness level of Herceptin Biosimilar market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Herceptin Biosimilar industry, describes the types of Herceptin Biosimilar market, the applications of major players and the market size, and deeply analyzes the current situation of the global Herceptin Biosimilar market and the development prospects and opportunities of Herceptin Biosimilar industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Herceptin Biosimilar market in Chapter 13.
By Player:
AryoGen Biopharma
Gedeon Richter
Celltrion
Biocon
The Instituto Vital Brazil
Amgen
Genor Biopharma
Mylan
Mabion
Roche
By Type:
Breast Cancer
Colorectal Cancer
Leukemia
Lymphoma
Other
By End-User:
Hospital & Clinics
Oncology Centers
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Herceptin Biosimilar Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Herceptin Biosimilar Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Herceptin Biosimilar Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Herceptin Biosimilar Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Herceptin Biosimilar Market Analysis and Outlook to 2022
-
7.1 Global Herceptin Biosimilar Consumption (2017-2022)
-
7.2 United States Herceptin Biosimilar Consumption (2017-2022)
-
7.3 Europe Herceptin Biosimilar Consumption (2017-2022)
-
7.4 China Herceptin Biosimilar Consumption (2017-2022)
-
7.5 Japan Herceptin Biosimilar Consumption (2017-2022)
-
7.6 India Herceptin Biosimilar Consumption (2017-2022)
-
7.7 South Korea Herceptin Biosimilar Consumption (2017-2022)
8 Region and Country-wise Herceptin Biosimilar Market Analysis and Outlook to 2028
-
8.1 Global Herceptin Biosimilar Consumption Forecast (2022-2028)
-
8.2 United States Herceptin Biosimilar Consumption Forecast (2022-2028)
-
8.3 Europe Herceptin Biosimilar Consumption Forecast (2022-2028)
-
8.4 China Herceptin Biosimilar Consumption Forecast (2022-2028)
-
8.5 Japan Herceptin Biosimilar Consumption Forecast (2022-2028)
-
8.6 India Herceptin Biosimilar Consumption Forecast (2022-2028)
-
8.7 South Korea Herceptin Biosimilar Consumption Forecast (2022-2028)
9 Global Herceptin Biosimilar Market Outlook by Types and Applications to 2022
-
9.1 Global Herceptin Biosimilar Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Leukemia Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Lymphoma Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Herceptin Biosimilar Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital & Clinics Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Oncology Centers Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Herceptin Biosimilar Market Outlook by Types and Applications to 2028
-
10.1 Global Herceptin Biosimilar Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Leukemia Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Herceptin Biosimilar Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital & Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Oncology Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Herceptin Biosimilar Import and Export Analysis (Top 5 Countries)
-
11.1 Global Herceptin Biosimilar Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Herceptin Biosimilar Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Herceptin Biosimilar Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Herceptin Biosimilar Market Competitive Analysis
-
14.1 AryoGen Biopharma
-
14.1.1 AryoGen Biopharma Company Details
-
14.1.2 AryoGen Biopharma Herceptin Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AryoGen Biopharma Herceptin Biosimilar Product and Service
-
14.2 Gedeon Richter
-
14.2.1 Gedeon Richter Company Details
-
14.2.2 Gedeon Richter Herceptin Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Gedeon Richter Herceptin Biosimilar Product and Service
-
14.3 Celltrion
-
14.3.1 Celltrion Company Details
-
14.3.2 Celltrion Herceptin Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Celltrion Herceptin Biosimilar Product and Service
-
14.4 Biocon
-
14.4.1 Biocon Company Details
-
14.4.2 Biocon Herceptin Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Biocon Herceptin Biosimilar Product and Service
-
14.5 The Instituto Vital Brazil
-
14.5.1 The Instituto Vital Brazil Company Details
-
14.5.2 The Instituto Vital Brazil Herceptin Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 The Instituto Vital Brazil Herceptin Biosimilar Product and Service
-
14.6 Amgen
-
14.6.1 Amgen Company Details
-
14.6.2 Amgen Herceptin Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Amgen Herceptin Biosimilar Product and Service
-
14.7 Genor Biopharma
-
14.7.1 Genor Biopharma Company Details
-
14.7.2 Genor Biopharma Herceptin Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Genor Biopharma Herceptin Biosimilar Product and Service
-
14.8 Mylan
-
14.8.1 Mylan Company Details
-
14.8.2 Mylan Herceptin Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Mylan Herceptin Biosimilar Product and Service
-
14.9 Mabion
-
14.9.1 Mabion Company Details
-
14.9.2 Mabion Herceptin Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Mabion Herceptin Biosimilar Product and Service
-
14.10 Roche
-
14.10.1 Roche Company Details
-
14.10.2 Roche Herceptin Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Roche Herceptin Biosimilar Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Herceptin Biosimilar
-
Figure Herceptin Biosimilar Picture
-
Table Global Herceptin Biosimilar Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Herceptin Biosimilar Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Herceptin Biosimilar Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Herceptin Biosimilar Consumption by Country (2017-2022)
-
Figure United States Herceptin Biosimilar Consumption and Growth Rate (2017-2022)
-
Table Europe Herceptin Biosimilar Consumption and Growth Rate (2017-2022)
-
Figure China Herceptin Biosimilar Consumption and Growth Rate (2017-2022)
-
Figure Japan Herceptin Biosimilar Consumption and Growth Rate (2017-2022)
-
Figure India Herceptin Biosimilar Consumption and Growth Rate (2017-2022)
-
Figure South Korea Herceptin Biosimilar Consumption and Growth Rate (2017-2022)
-
Figure Global Herceptin Biosimilar Consumption Forecast by Country (2022-2028)
-
Figure United States Herceptin Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Herceptin Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Herceptin Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Herceptin Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Herceptin Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Herceptin Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Leukemia Consumption and Growth Rate (2017-2022)
-
Figure Global Lymphoma Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital & Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Leukemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital & Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Herceptin Biosimilar Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Herceptin Biosimilar Export by Region (Top 5 Countries) (2017-2028)
-
Table AryoGen Biopharma (Foundation Year, Company Profile and etc.)
-
Table AryoGen Biopharma Herceptin Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table AryoGen Biopharma Herceptin Biosimilar Product and Service
-
Table Gedeon Richter (Foundation Year, Company Profile and etc.)
-
Table Gedeon Richter Herceptin Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gedeon Richter Herceptin Biosimilar Product and Service
-
Table Celltrion (Foundation Year, Company Profile and etc.)
-
Table Celltrion Herceptin Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celltrion Herceptin Biosimilar Product and Service
-
Table Biocon (Foundation Year, Company Profile and etc.)
-
Table Biocon Herceptin Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Herceptin Biosimilar Product and Service
-
Table The Instituto Vital Brazil (Foundation Year, Company Profile and etc.)
-
Table The Instituto Vital Brazil Herceptin Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table The Instituto Vital Brazil Herceptin Biosimilar Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Herceptin Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Herceptin Biosimilar Product and Service
-
Table Genor Biopharma (Foundation Year, Company Profile and etc.)
-
Table Genor Biopharma Herceptin Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genor Biopharma Herceptin Biosimilar Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Herceptin Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Herceptin Biosimilar Product and Service
-
Table Mabion (Foundation Year, Company Profile and etc.)
-
Table Mabion Herceptin Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mabion Herceptin Biosimilar Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Herceptin Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Herceptin Biosimilar Product and Service
-
